Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County

Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolayemi, Oluwadamilola, Bogart, Laura M., Storholm, Erik D., Goodman-Meza, David, Rosenberg-Carlson, Elena, Cohen, Rebecca, Kao, Uyen, Shoptaw, Steve, Landovitz, Raphael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812879/
https://www.ncbi.nlm.nih.gov/pubmed/35113892
http://dx.doi.org/10.1371/journal.pone.0262926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812879/
https://www.ncbi.nlm.nih.gov/pubmed/35113892
http://dx.doi.org/10.1371/journal.pone.0262926

Ejemplares similares